In hepatocellular carcinoma (HCC), the induction of Kcr through siRNAs targeting histone deacetylases (HDACs) or HDAC inhibitors inhibits hepatoma cell motility and proliferation [14]. The gene discussed is CLEC4F; the disease is hepatocellular carcinoma.